BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9507686)

  • 1. [Examination of blood coagulation in Schoenlein-Henoch disease of children].
    Styczyński J; Drabik T; Pałgan I
    Wiad Lek; 1997; 50(7-9):190-2. PubMed ID: 9507686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombocytosis and reduced levels of factor VIII in rheumatoid purpura in children].
    Bost M; Kolodie L; Pouzol P; Dechelette E; Joannard A; Andreani P
    Pediatrie; 1986; 41(5):401-11. PubMed ID: 3101037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of coagulation parameters in the Schönlein-Henoch syndrome. Diagnostic value of factor XIII].
    Barberio G; Manganaro R; Ruggeri C; Cambria R; Gattarello A; Gemelli M
    Minerva Pediatr; 1981 Aug; 33(16):817-20. PubMed ID: 7311944
    [No Abstract]   [Full Text] [Related]  

  • 4. Henoch-Schönlein purpura in a child with Guillain-Barré syndrome.
    Fuchigami T; Hasegawa M; Hashimoto K; Fujita Y; Inamo Y
    Pediatr Neurol; 2010 Dec; 43(6):431-4. PubMed ID: 21093736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of factor XIII in Schönlein-Henoch purpura in childhood (author's transl)].
    Dalens B; Bezou MJ; Goumy P; Déméocq F; Menut G
    Arch Fr Pediatr; 1980 Feb; 37(2):99-101. PubMed ID: 7396652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Henoch-Schoenlein purpura (author's transl)].
    Niederhoff H; Pernice W; Sedlacek HH; Schindera F; Schütte B; Strassburg HM
    Dtsch Med Wochenschr; 1979 Nov; 104(44):1567-71. PubMed ID: 498981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura.
    Brendel-Müller K; Hahn A; Schneppenheim R; Santer R
    Pediatr Nephrol; 2001 Dec; 16(12):1084-8. PubMed ID: 11793106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of disorders of the hemostatic system in the pathogenesis of hemorrhagic vasculitis in children].
    Fedorov AV
    Vopr Okhr Materin Det; 1979 Jul; 24(7):36-40. PubMed ID: 524785
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased factor XIII activity during severe Henoch-Schoenlein purpura -- does it play a role?
    Prenzel F; Pfäffle R; Thiele F; Schuster V
    Klin Padiatr; 2006; 218(3):174-6. PubMed ID: 16688675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on acute pancreatitis: a rare presenting feature of Henoch-Schönlein purpura.
    Shin JI; Lee JS
    J Paediatr Child Health; 2008 Nov; 44(11):678-9; author reply 679. PubMed ID: 19012648
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating the child with purpura.
    Leung AK; Chan KW
    Am Fam Physician; 2001 Aug; 64(3):419-28. PubMed ID: 11515831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factor XIII].
    Takahashi I; Fukue H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():660-2. PubMed ID: 15658417
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Japanese Pediatric Group.
    Fukui H; Kamitsuji H; Nagao T; Yamada K; Akatsuka J; Inagaki M; Shike S; Kobayashi Y; Yoshioka K; Maki S
    Thromb Res; 1989 Dec; 56(6):667-75. PubMed ID: 2699100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.
    Kamitsuji H; Tani K; Yasui M; Taniguchi A; Taira K; Tsukada S; Iida Y; Kanki H; Fukui H
    Eur J Pediatr; 1987 Sep; 146(5):519-23. PubMed ID: 3678279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephropathy in the course of Schönlein-Henoch purpura].
    Rapacka E; Ostrowska-Nawarycz L; Baszczyński J; Makowska J; Kudzin J; Makowski M; Kudzin A; Górski P
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():31-2. PubMed ID: 11081341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation abnormalities in the Schönlein-Henoch syndrome in adults.
    Boros G; Gofman L; Sámsik J; Nagy J; Hámori A; Deák G
    Acta Med Acad Sci Hung; 1979; 36(2):151-66. PubMed ID: 397710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura.
    De Mattia D; Penza R; Giordano P; Del Vecchio GC; Aceto G; Altomare M; Schettini F
    Pediatr Nephrol; 1995 Oct; 9(5):603-5. PubMed ID: 8580019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII (fibrin stabilising factor) in Henoch-Schönlein's purpura.
    Henriksson P; Hedner U; Nilsson IM
    Acta Paediatr Scand; 1977 May; 66(3):273-7. PubMed ID: 301339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional state of the kidneys according to radioisotope renographic data in children with a catamnesis of Schönlein-Henoch purpura].
    Morgunova MA; Gusev AI; Kozelkova MG
    Vopr Okhr Materin Det; 1980 May; 25(5):33-5. PubMed ID: 7385700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.